AU2014204346B2 - Method for obtaining immuno-suppressive dendritic cells - Google Patents
Method for obtaining immuno-suppressive dendritic cells Download PDFInfo
- Publication number
- AU2014204346B2 AU2014204346B2 AU2014204346A AU2014204346A AU2014204346B2 AU 2014204346 B2 AU2014204346 B2 AU 2014204346B2 AU 2014204346 A AU2014204346 A AU 2014204346A AU 2014204346 A AU2014204346 A AU 2014204346A AU 2014204346 B2 AU2014204346 B2 AU 2014204346B2
- Authority
- AU
- Australia
- Prior art keywords
- monocytes
- platelets
- dendritic cells
- immuno
- mammalian subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
- C12N5/064—Immunosuppressive dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/22—Immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/418—Antigens related to induction of tolerance to non-self
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
- C12N2502/115—Platelets, megakaryocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
- C12N2506/115—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells from monocytes, from macrophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2521/00—Culture process characterised by the use of hydrostatic pressure, flow or shear forces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2529/00—Culture process characterised by the use of electromagnetic stimulation
- C12N2529/10—Stimulation by light
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361748550P | 2013-01-03 | 2013-01-03 | |
| GB1300052.6 | 2013-01-03 | ||
| US61/748,550 | 2013-01-03 | ||
| GBGB1300052.6A GB201300052D0 (en) | 2013-01-03 | 2013-01-03 | Method for obtaining immuno-suppressive dendritic cells |
| PCT/EP2014/050012 WO2014106631A1 (en) | 2013-01-03 | 2014-01-02 | Method for obtaining immuno-suppressive dendritic cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2014204346A1 AU2014204346A1 (en) | 2015-07-02 |
| AU2014204346B2 true AU2014204346B2 (en) | 2017-08-31 |
Family
ID=47747914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014204346A Active AU2014204346B2 (en) | 2013-01-03 | 2014-01-02 | Method for obtaining immuno-suppressive dendritic cells |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20160130552A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3719118A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2016509474A (cg-RX-API-DMAC7.html) |
| KR (3) | KR20180010345A (cg-RX-API-DMAC7.html) |
| CN (2) | CN104955940A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014204346B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2897113C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2941484T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2795927T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201300052D0 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2941484T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014106631A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013059343A1 (en) | 2011-10-17 | 2013-04-25 | Massachusetts Institute Of Technology | Intracellular delivery |
| US10124336B2 (en) | 2013-08-16 | 2018-11-13 | Massachusetts Institute Of Technology | Selective delivery of material to cells |
| GB201413665D0 (en) * | 2014-07-03 | 2014-09-17 | Transimmune Ag And Yale University | Method for obtaining globally activated monocytes |
| CN122564053A (zh) | 2014-10-31 | 2026-08-14 | 麻省理工学院 | 递送生物分子至免疫细胞 |
| WO2016077761A1 (en) | 2014-11-14 | 2016-05-19 | Massachusetts Institute Of Technology | Disruption and field enabled delivery of compounds and compositions into cells |
| AU2016206870B2 (en) | 2015-01-12 | 2022-02-17 | Massachusetts Institute Of Technology | Gene editing through microfluidic delivery |
| GB201513278D0 (en) * | 2015-07-03 | 2015-09-09 | Transimmune Ag And Yale University | Device and method for obtaining immunostimulatory antigen-presenting cells |
| JP6925984B2 (ja) | 2015-07-09 | 2021-08-25 | マサチューセッツ インスティテュート オブ テクノロジー | 無核細胞への物質の送達 |
| US10946095B2 (en) | 2015-09-02 | 2021-03-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Antibodies specific to human T-cell immunoglobulin and ITIM domain (TIGIT) |
| EP3518942A4 (en) * | 2016-09-29 | 2020-05-27 | Hadasit Medical Research Services&Development Ltd. | DENDRITIC CELL PREPARATIONS, COMPOSITIONS AND METHODS OF USE |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| CN109701019B (zh) * | 2019-01-04 | 2021-07-16 | 中国人民解放军第二军医大学 | 一种新的长链非编码RNA即lnc-Dpf3、其序列、免疫效应及用途 |
| BR112021013193A2 (pt) | 2019-01-07 | 2021-09-28 | Shattuck Labs, Inc. | Proteínas heterodiméricas para modulação de células t gama delta |
| KR102904431B1 (ko) * | 2021-05-07 | 2025-12-26 | (주)나노팬텍 | 수지상 세포의 배양 방법 |
| WO2023283514A1 (en) * | 2021-07-06 | 2023-01-12 | Vanderbilt University | Fluid shear stress for ex vivo activation of immune effector cells |
| EP4376860A1 (en) | 2021-07-29 | 2024-06-05 | Transimmune AG | Methods for selectively reducing immunogenicity in a transplant |
| US20250375477A1 (en) * | 2021-07-29 | 2025-12-11 | Transimmune Ag | Selective tolerization - methods of selectively generating tolerogenic dendritic cells |
| CN121335708A (zh) | 2023-05-01 | 2026-01-13 | 耶鲁大学 | 用于疫苗接种的抗原特异性生理性树突状细胞 |
| JP2026516460A (ja) | 2023-05-01 | 2026-05-25 | エール・ユニバーシティ | 療法用の抗原特異的生理的樹状細胞 |
| CN118256609B (zh) * | 2024-02-06 | 2024-08-30 | 湖北文理学院 | Tm9sf1标志物在监测自身免疫性疾病病程中的应用 |
| WO2026074195A1 (en) | 2024-10-05 | 2026-04-09 | Yale University | Cytokine loaded activated dendritic cells |
| WO2026074196A1 (en) | 2024-10-05 | 2026-04-09 | Yale University | Checkpoint inhibitor loaded activated dendritic cells |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011137365A1 (en) * | 2010-04-30 | 2011-11-03 | Yale University | Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000062818A1 (en) | 1999-04-20 | 2000-10-26 | Richard Leslie Edelson | Differentiation of monocytes into functional dendritic cells |
| EP2358739A1 (en) * | 2008-11-18 | 2011-08-24 | The University Of Queensland | Peptide conjugates for suppressing an immune response, methods of making and uses therefor |
-
2013
- 2013-01-03 GB GBGB1300052.6A patent/GB201300052D0/en not_active Ceased
-
2014
- 2014-01-02 KR KR1020187002019A patent/KR20180010345A/ko not_active Ceased
- 2014-01-02 CA CA2897113A patent/CA2897113C/en active Active
- 2014-01-02 AU AU2014204346A patent/AU2014204346B2/en active Active
- 2014-01-02 KR KR1020157020667A patent/KR20150122639A/ko not_active Ceased
- 2014-01-02 ES ES14700050T patent/ES2795927T3/es active Active
- 2014-01-02 US US14/759,016 patent/US20160130552A1/en not_active Abandoned
- 2014-01-02 WO PCT/EP2014/050012 patent/WO2014106631A1/en not_active Ceased
- 2014-01-02 DK DK14700050.9T patent/DK2941484T3/da active
- 2014-01-02 KR KR1020207025108A patent/KR20200106217A/ko not_active Ceased
- 2014-01-02 CN CN201480003942.3A patent/CN104955940A/zh active Pending
- 2014-01-02 EP EP20160436.0A patent/EP3719118A1/en active Pending
- 2014-01-02 PL PL14700050T patent/PL2941484T3/pl unknown
- 2014-01-02 CN CN202111008277.5A patent/CN114410581A/zh active Pending
- 2014-01-02 EP EP14700050.9A patent/EP2941484B1/en active Active
- 2014-01-02 JP JP2015551179A patent/JP2016509474A/ja active Pending
-
2017
- 2017-10-25 JP JP2017205758A patent/JP6599958B2/ja active Active
-
2019
- 2019-10-03 JP JP2019182703A patent/JP6804607B2/ja active Active
-
2021
- 2021-10-21 US US17/507,002 patent/US20220259556A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011137365A1 (en) * | 2010-04-30 | 2011-11-03 | Yale University | Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
Non-Patent Citations (2)
| Title |
|---|
| Baird AH et al., Journal of Investigative Dermatology, April 2010, Vol. 130, Suppl. 1, page S136, for the Annual Meeting of the Society-for-Investigative Dermatology; Atlanta, GA, USA; 05-08 MAY, 2010. ISSN: 0022-202X. * |
| Spisek, Radek, et al., 'Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease', Transfusion, 2006, Vol. 46, pages 55-65. * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB201300052D0 (en) | 2013-02-20 |
| EP2941484B1 (en) | 2020-03-04 |
| JP2018046837A (ja) | 2018-03-29 |
| US20160130552A1 (en) | 2016-05-12 |
| JP6599958B2 (ja) | 2019-10-30 |
| JP2016509474A (ja) | 2016-03-31 |
| KR20180010345A (ko) | 2018-01-30 |
| HK1210626A1 (en) | 2016-04-29 |
| CA2897113C (en) | 2024-03-12 |
| PL2941484T3 (pl) | 2020-10-05 |
| US20220259556A1 (en) | 2022-08-18 |
| CN104955940A (zh) | 2015-09-30 |
| JP6804607B2 (ja) | 2020-12-23 |
| ES2795927T3 (es) | 2020-11-25 |
| KR20150122639A (ko) | 2015-11-02 |
| DK2941484T3 (da) | 2020-06-02 |
| JP2020018315A (ja) | 2020-02-06 |
| EP2941484A1 (en) | 2015-11-11 |
| WO2014106631A1 (en) | 2014-07-10 |
| CA2897113A1 (en) | 2014-07-10 |
| CN114410581A (zh) | 2022-04-29 |
| AU2014204346A1 (en) | 2015-07-02 |
| KR20200106217A (ko) | 2020-09-11 |
| EP3719118A1 (en) | 2020-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220259556A1 (en) | Method for obtaining immuno-suppressive dendritic cells | |
| US20220112462A1 (en) | Method for obtaining immuno-stimulatory dendritic cells | |
| US12364755B2 (en) | Method for obtaining globally activated monocytes | |
| HK40038738A (en) | Method for obtaining immuno-suppressive dendritic cells | |
| HK40042400B (en) | Method for obtaining immuno-stimulatory dendritic cells | |
| HK40042400A (en) | Method for obtaining immuno-stimulatory dendritic cells | |
| CA2954090C (en) | Method for obtaining globally activated monocytes | |
| HK40068512B (en) | Method for obtaining globally activated monocytes | |
| HK40068512A (en) | Method for obtaining globally activated monocytes | |
| HK1210626B (en) | Method for obtaining immuno-suppressive dendritic cells | |
| HK1210625B (en) | Method for obtaining immuno-stimulatory dendritic cells | |
| HK1236835B (en) | Globally activated monocytes for use in treating cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |